The healthcare sector has seen many developments and innovations in the digital healthcare space worldwide. The innovations span across the spectrum including new drug discovery, drug delivery methods, packaging and distribution, diagnostics, and treatment methods. One of the disruptive tech-led innovations of the 21st century has been the assistive robotic technology for surgeries. Due to its rising popularity, the minimally invasive surgeries are today almost becoming synonymous with robot-assisted surgeries in India's top metropolitan centers.
The robot-assisted surgery (RAS) helps the operating doctors to perform surgical procedures with precision, flexibility, and control. With chronic and infectious diseases on the rise, higher disposable incomes, and growing patient demand for minimally invasive surgeries, robotassisted surgeries are on the rise.
The market size
According to a market research report released by Global Market Insights, the surgical robots market crossed $5.2 billion in 2021 and is expected to grow by 17.6 percent annually from 2022 to 2030. The market will touch $22.8 billion in value terms by the year 2030.
The trend is not too different in India too. Following the first Da Vinci surgical robot installation at New Delhi's All India Institute of Medical Sciences (AIIMS) in the year 2006, India has seen a steady rise in adoption of robot-assisted surgery (RAS).
As per available data, India today has 70-plus installations of surgical robots at different hospitals that regularly carry out hundreds of robot-assisted surgeries (RAS). As per some market estimates, there are more than 500 surgeons in India who are trained on and are using assistive robotic technology for surgeries at private as well as some government hospitals.
Bu hikaye Healthcare Radius dergisinin November 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Healthcare Radius dergisinin November 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.